Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis [Phase 2]
A Phase 2 trial evaluating XP23829 in adults with moderate-to-severe chronic plaque psoriasis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis [Phase 4]
Phase 4 trial updating on efficacy and safety of secukinumab in adult patients with skin types IV-VI and moderate to severe plaque psoriasis…
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: MYL-1401A Efficacy and Safety Comparability Study to Humira® [Phase 3]
Phase 3 trial comparing MYL-1401A to Humira for psoriasis, arthritis, and psoriatic arthritis has completed.
-
FDA approval · 2022-02-18FDA Approved: BETAMETHASONE DIPROPIONATE USP, 0.05% — Original Application (TruPharma LLC)
FDA approved the Original Application for Betamethasone Dipropionate USP, 0.05% (topical corticosteroid) submitted by TruPharma LLC. It is a…
-
CLINICAL_TRIALS trial_result · 2022-02-09Clinical Trial Update: A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis [Phase 2]
Phase 2 dose-ranging trial evaluating ruxolitinib phosphate cream in plaque psoriasis has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis [Phase 2]
Phase 2 open-label study assessing safety and efficacy of a topical investigational drug for psoriasis; study completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis [Phase 2]
Phase 2 trial evaluating ruxolitinib phosphate cream for plaque psoriasis has completed with results posted.
-
FDA approval · 2022-02-02FDA Approved: CYCLOSPORINE — Original Application (Mylan Pharmaceuticals Inc.)
The FDA approved Mylan Pharmaceuticals' original application for cyclosporine, a generic immunosuppressant product. This makes a generic cyc…
-
CLINICAL_TRIALS research · 2022-01-24Clinical Trial Update: Omentin-1 Level in Psoriatic Patients Treated With Narrowband Ultraviolet B Phototherapy Versus Acitretin [Phase 4]
Phase 4 trial comparing omentin-1 levels in psoriatic patients treated with narrowband UVB phototherapy versus acitretin; completed.
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of Life [Phase 4]
A Phase 4 trial evaluating apremilast (CC-10004) in adults with plaque psoriasis and impaired quality of life assessed quality of life, effi…
-
CLINICAL_TRIALS trial_result · 2022-01-06Clinical Trial Update: Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging [Phase 4]
A Phase 4 clinical trial evaluating etanercept therapy for nails psoriasis monitoring using noninvasive imaging.
-
CLINICAL_TRIALS trial_result · 2022-01-03Clinical Trial Update: A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis [Phase 3]
Phase 3 clinical trial evaluating guselkumab for palmoplantar-non-pustular psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) [Phase 2]
Phase 2 trial assessing safety and effectiveness of the Live Zoster Vaccine in patients using anti-TNF therapy for inflammatory diseases, wi…
-
CLINICAL_TRIALS trial_result · 2021-11-01Clinical Trial Update: Safety and Efficacy of Secukinumab in Mild Psoriasis [Phase 2]
Phase 2 trial assessing safety and efficacy of secukinumab in mild psoriasis has completed with results posted.
-
FDA approval · 2021-10-25FDA Approved: METHOTREXATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Methotrexate by Hikma Pharmaceuticals USA Inc. (ANDA089342).
-
FDA approval · 2021-10-25FDA Approved: METHOTREXATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approves a supplemental application for Methotrexate by Hikma Pharmaceuticals USA Inc., enabling a new generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2021-10-13Clinical Trial Update: Efficacy and Safety Study of Hemay005 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 study assessing efficacy and safety of Hemay005 in moderate to severe plaque psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-05Clinical Trial Update: Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis [Phase 2]
Phase 2 clinical trial update for topical BMX-010 in subjects with psoriasis and atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-01Clinical Trial Update: Phase IV Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Psoriasis in Adults [Phase 4]
Phase IV clinical study update for benvimod cream in adults with mild to moderate psoriasis (Phase 4).
-
CLINICAL_TRIALS trial_result · 2021-08-27Clinical Trial Update: A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis [Phase 2]
Phase 2 trial evaluating safety and efficacy of PF-06826647 for moderate to severe plaque psoriasis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis [Phase 3]
A Phase 3 pediatric trial in children and adolescents with severe plaque psoriasis has completed; results were posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 study evaluating the efficacy and safety of JTE-451 in moderate to severe plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis [Phase 2]
A Phase 2b trial evaluating the efficacy, safety, and tolerability of M1095 (Sonelokimab) in moderate to severe psoriasis has completed, wit…
-
CLINICAL_TRIALS withdrawal · 2021-07-23Clinical Trial Update: SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE [Phase 4]
A Phase 4 clinical trial exploring systemic inflammation and microvascular disease prevention in psoriasis and psoriatic arthritis has been …
-
CLINICAL_TRIALS trial_result · 2021-07-21Clinical Trial Update: Topical Methotrexate Microemulsion in the Treatment of Plaque Psoriasis [Phase 4]
Phase 4 trial update for topical methotrexate microemulsion in plaque psoriasis; status currently UNKNOWN.